Home
News
Screeners
Insights
Amkay Products
55.
50
-2.50
(-4.31%)
Market Cap
₹48.04 Cr
PE Ratio
21.72
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-4.31%
1M
-0.88%
6M
-11.76%
1Y
+28.47%
5Y
-49.42%
View Company Insights
Latest news about Amkay Products
Amkay Products holds 19th AGM via video conferencing on Sep 30
Oct 01, 2026
Amkay Products Limited held its 19th AGM on September 30, 2026, via Video Conferencing. Total of 376 shareholders were on the register as of the record date, September 23, 2026. Nine shareholders participated digitally: four from the promoter group and five from the public. No physical attendance was recorded; voting was conducted through remote e-voting and VC.
Amkay Products schedules 19th AGM for September 30, 2026
Sep 10, 2026
Amkay Products FY26 net profit falls 30.8% to ₹231.10 lakh
May 28, 2026
Amkay Products board to consider FY26 results on May 28
May 20, 2026
Amkay Products Limited Files Quarterly Compliance Certificate for Q4 FY26
Apr 06, 2026
More news about Amkay Products
25
Mar 26
Amkay Products Limited Announces Trading Window Closure from April 1, 2026 Under SEBI Insider Trading Regulations
Amkay Products Limited has announced trading window closure for designated persons from April 1, 2026, until 48 hours after FY26 financial results declaration. The closure complies with SEBI Insider Trading Regulations 2015 and BSE Circular LIST/COMP/01/2019-20. The medical devices manufacturer communicated this regulatory requirement to BSE Limited on March 25, 2026, through Managing Director Kashyap Pravin Mody.
13
Nov 25
Amkay Products Reports Widened Loss in Half-Year Results
Amkay Products Limited, a medical device manufacturer, reported financial results for H1 2025 ending September 30. Despite a 7.8% increase in revenue to Rs 2,340.45 lakhs, the company's net loss widened by 30.1% to Rs 196.80 lakhs compared to H1 2024. Total expenses rose to Rs 2,071.65 lakhs. The Board approved these unaudited results on November 12, 2025, with statutory auditors issuing an unmodified opinion. The company will reopen its trading window 48 hours after the public announcement of results, in compliance with SEBI regulations.
Amkay Products
55.
50
-
2.
50
(-
4.
31
%)
1 Year Returns:
+28.47%
Industry Peers
Poly Medicure
1,470.10
(-
5.
20
%)
Tarsons Products
300.00
(-
4.
84
%)
Q-Line Biotech
572.45
(-
4.
68
%)
Laxmi Dental
177.96
(-
2.
11
%)
Hemant Surgical Industries
598.00
(-
3.
33
%)
Vasa Denticity
440.00
(0.0%)
Osel Devices
337.20
(-
2.
67
%)
Fabtech Technologies
126.55
(-
3.
68
%)
Prevest Denpro
392.80
(-
3.
01
%)
QMS Medical Allied Services
173.89
(-
1.
67
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar